Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma
Open Access
- 31 December 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 112 (6) , 1229-1236
- https://doi.org/10.1016/j.jaci.2003.09.025
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) Study: Rationale and DesignControlled Clinical Trials, 2001
- Estimating log models: to transform or not to transform?Journal of Health Economics, 2001
- Asthma pharmacotherapy and utilization by children in 3 managed care organizationsJournal of Allergy and Clinical Immunology, 2000
- Trends in the cost of illness for asthma in the United States, 1985-1994Journal of Allergy and Clinical Immunology, 2000
- Economic Evaluation Alongside Multinational Clinical Trials:Study Considerations for GUSTO iibInternational Journal of Technology Assessment in Health Care, 1997
- Effect of Early vs Late Intervention With Inhaled Corticosteroids in AsthmaChest, 1995
- Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild AsthmaNew England Journal of Medicine, 1994
- Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic childrenRespiratory Medicine, 1994
- Comparison of a β2-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected AsthmaNew England Journal of Medicine, 1991
- ADVANTAGES OF HIGH-DOSE INHALED BUDESONIDEThe Lancet, 1988